← All Sponsors

SPONSOR

GlaxoSmithKline

Total Trials

16

Recruiting

16

Phases

Phase 1, Phase 3, Phase 1, Phase 2, Phase 2

Conditions studied: Colitis, Ulcerative Asthma Chickenpox Colonic Neoplasms Neoplasms, Colon Malaria, Falciparum Lung Cancer, Non-Small Cell Gastrointestinal Neoplasms Respiratory Syncytial Virus Infections Pulmonary Disease, Chronic Obstructive

NCT06681181 Phase 1

A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants

Colitis, Ulcerative

The Extended Salford Lung Study ("Ex-SLS") Data Access Project

NCT06806137 Phase 3

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

NCT05855200 Phase 3

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Colonic Neoplasms

NCT06171113 Phase 1

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

Malaria, Falciparum

NCT05757102 Phase 3

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

NCT06405230 Phase 1, Phase 2

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Lung Cancer, Non-Small Cell

NCT06885034 Phase 1, Phase 2

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed

Gastrointestinal Neoplasms

NCT07220109 Phase 3

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Infections

NCT07177339 Phase 3

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Pulmonary Disease, Chronic Obstructive

NCT07168356 Phase 1

A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

NCT07099898 Phase 3

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

Neoplasms, Lung

NCT06433921 Phase 1

A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive

NCT04006808 Phase 1, Phase 2

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

NCT04641247 Phase 2

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Ovarian Neoplasms

NCT06990880 Phase 1, Phase 2

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

Neoplasms, Prostate